Kineta (KA) Stock Analysis
NASDAQHealthcareBiotechnology
What Kineta does
Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing immunotherapies, with a focus on oncology, neuroscience, and biodefense applications. The company engages in partnerships with a variety of entities, including private companies, government bodies, and other industry stakeholders. Among its significant strategic collaborators are Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Established in 2007, Kineta, Inc. was previously known as Lecura, Inc. and has its base of operations in Seattle, Washington.
Key metrics
ETFs linked to KA
Broad-market and Healthcare sector ETFs an investor holding Kineta is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how KA fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze KA in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Kineta?
- Kineta trades under the ticker KA on NASDAQ.
- Which exchange is KA listed on?
- KA is listed on NASDAQ.
- What sector does Kineta operate in?
- Kineta is classified in the Healthcare sector (Biotechnology industry).
- How can PortView help analyze KA in a portfolio?
- PortView shows KA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.